ArticleChembiochem : a European journal of chemical biology2026
Structural Basis for Nucleobase Activation by the Adenine DNA Glycosylase MutY.
Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
The DNA glycosylase MutY excises adenine when mispaired with oxidized guanine (OG). While it is understood that inappropriate adenine excision would be catastrophic, the mechanism by which MutY activity is kept in check and only licensed at OG:A lesions is unknown. To explore the structural basis for nucleobase activation, we tested kinetic and structural consequences following replacement of the catalytic Glu, a signature residue for MutY. E43Q and E43S substitution variants of MutY from Geobacillus stearothermophilus, though severely impaired, retained measurable activity. X-ray crystal structures showed the substrate nucleobase in an anti conformation, rotated by 180° from the syn conformation seen in previous substrate complexes. Remarkably, the AP product was observed as the alpha-anomer configuration when generated by these Glu-replacement variants, completely different from the beta-anomer AP product expected for the wild-type enzyme and seen directly for other cancer-associated variants. Our results suggest a mechanism for regulating MutY, whereby Glu engagement with the syn conformation of the nucleobase licenses a "go ahead" state for adenine excision only at OG:A lesions, while Glu dis-engagement establishes an "on hold" state to avoid inappropriate activity elsewhere.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.